Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | oxidoreductase-protein, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus multilocularis | methionine synthase reductase | 0.0201 | 0.3297 | 0.3297 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0109 | 0.1526 | 0.2803 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0032 | 0.0061 | 0.0107 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0125 | 0.1833 | 0.3226 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0552 | 1 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0032 | 0.0061 | 0.0061 |
Brugia malayi | flavodoxin family protein | 0.0326 | 0.5682 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0326 | 0.5682 | 1 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0162 | 0.2541 | 0.4473 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0109 | 0.1526 | 0.2685 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.1526 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0326 | 0.5682 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0032 | 0.0061 | 0.0107 |
Leishmania major | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Schistosoma mansoni | cytochrome B5 | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0326 | 0.5682 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0109 | 0.1526 | 0.2685 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.0037 | 0.0157 | 0.0289 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Leishmania major | hypothetical protein, conserved | 0.0125 | 0.1833 | 0.3226 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0201 | 0.3297 | 0.5804 |
Onchocerca volvulus | 0.0037 | 0.0157 | 1 | |
Schistosoma mansoni | lamin | 0.0032 | 0.0061 | 0.0107 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.0037 | 0.0157 | 0.0157 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0289 | 0.4973 | 1 |
Echinococcus multilocularis | lamin | 0.0032 | 0.0061 | 0.0061 |
Brugia malayi | intermediate filament protein | 0.0032 | 0.0061 | 0.0107 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0201 | 0.3297 | 0.5804 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0326 | 0.5682 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0326 | 0.5682 | 0.5682 |
Leishmania major | oxidoreductase-like protein | 0.0037 | 0.0157 | 0.0277 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0326 | 0.5682 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0125 | 0.1833 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0125 | 0.1833 | 0.3226 |
Plasmodium falciparum | glutathione reductase | 0.0314 | 0.5442 | 0.9579 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0061 | 0.0107 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0125 | 0.1833 | 1 |
Mycobacterium ulcerans | oxygenase | 0.0037 | 0.0157 | 0.0277 |
Onchocerca volvulus | 0.0032 | 0.0061 | 0.3868 | |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0326 | 0.5682 | 1 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.2685 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0109 | 0.1526 | 0.2803 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0326 | 0.5682 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Leishmania major | p450 reductase, putative | 0.0326 | 0.5682 | 1 |
Leishmania major | cytochrome P450 reductase, putative | 0.0289 | 0.4973 | 0.8753 |
Trypanosoma cruzi | p450 reductase, putative | 0.0326 | 0.5682 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.2685 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0109 | 0.1526 | 0.2685 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0125 | 0.1833 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0289 | 0.4973 | 0.8753 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0125 | 0.1833 | 0.3226 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0109 | 0.1526 | 0.2803 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Treponema pallidum | flavodoxin | 0.0125 | 0.1833 | 1 |
Giardia lamblia | Hypothetical protein | 0.0289 | 0.4973 | 1 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium falciparum | ferredoxin--NADP reductase | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0032 | 0.0061 | 0.0107 |
Brugia malayi | FAD binding domain containing protein | 0.0201 | 0.3297 | 0.5804 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0326 | 0.5682 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0109 | 0.1526 | 0.3068 |
Brugia malayi | glutathione reductase | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma cruzi | reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.0037 | 0.0157 | 0.0289 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0125 | 0.1833 | 0.3226 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0109 | 0.1526 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Leishmania major | nitrate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus multilocularis | cytochrome b5 reductase 4 | 0.0037 | 0.0157 | 0.0157 |
Chlamydia trachomatis | Na(+)-translocating NADH-quinone reductase subunit F | 0.0037 | 0.0157 | 0.0477 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.1526 |
Plasmodium falciparum | thioredoxin reductase | 0.0109 | 0.1526 | 0.2685 |
Plasmodium vivax | oxidoreductase NAD-binding domain containing protein | 0.0037 | 0.0157 | 0.0277 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.008 | 0.0974 | 0.1715 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Echinococcus multilocularis | musashi | 0.0032 | 0.0061 | 0.0061 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0164 | 0.2589 | 0.4557 |
Echinococcus granulosus | lamin | 0.0032 | 0.0061 | 0.0061 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0125 | 0.1833 | 0.3226 |
Trypanosoma cruzi | nitrate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0109 | 0.1526 | 0.2685 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0109 | 0.1526 | 0.4627 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0314 | 0.5442 | 0.5442 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0037 | 0.0157 | 0.0289 |
Giardia lamblia | Flavohemoprotein lateral transfer candidate | 0.0037 | 0.0157 | 0.0316 |
Trypanosoma brucei | trypanothione reductase | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.2685 |
Mycobacterium ulcerans | monooxygenase | 0.0037 | 0.0157 | 0.0277 |
Brugia malayi | diaphorase | 0.0037 | 0.0157 | 0.0277 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0125 | 0.1833 | 0.3226 |
Brugia malayi | FAD binding domain containing protein | 0.0326 | 0.5682 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0109 | 0.1526 | 0.2685 |
Schistosoma mansoni | lamin | 0.0032 | 0.0061 | 0.0107 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0162 | 0.2541 | 0.467 |
Chlamydia trachomatis | sulfite reductase | 0.0201 | 0.3297 | 1 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0326 | 0.5682 | 1 |
Toxoplasma gondii | NADH-cytochrome b5 reductase 1, putative | 0.0037 | 0.0157 | 0.0289 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0125 | 0.1833 | 0.3226 |
Trypanosoma cruzi | p450 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0109 | 0.1526 | 0.2685 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0326 | 0.5682 | 0.5682 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0326 | 0.5682 | 0.5682 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0326 | 0.5682 | 0.5682 |
Brugia malayi | Thioredoxin reductase | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0109 | 0.1526 | 0.2685 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0109 | 0.1526 | 0.2685 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0109 | 0.1526 | 0.2685 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0314 | 0.5442 | 0.9579 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.008 | 0.0974 | 0.1715 |
Loa Loa (eye worm) | diaphorase | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium ulcerans | flavodoxin reductase Hmp | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0037 | 0.0157 | 0.0289 |
Plasmodium vivax | hypothetical protein, conserved | 0.0125 | 0.1833 | 0.3226 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0109 | 0.1526 | 0.2685 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0109 | 0.1526 | 0.2685 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0125 | 0.1833 | 0.3226 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0109 | 0.1526 | 0.2685 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0326 | 0.5682 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0314 | 0.5442 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0032 | 0.0061 | 0.0061 |
Trypanosoma cruzi | cytochrome-b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0289 | 0.4973 | 0.8753 |
Plasmodium falciparum | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0314 | 0.5442 | 0.9579 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0326 | 0.5682 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0326 | 0.5682 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0032 | 0.0061 | 0.0107 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0109 | 0.1526 | 0.2803 |
Leishmania major | NADH-dependent fumarate reductase-like protein | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0125 | 0.1833 | 0.3226 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Toxoplasma gondii | ferredoxin NADP+ oxidoreductase FNR | 0.0037 | 0.0157 | 0.0289 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0552 | 1 | 1 |
Mycobacterium tuberculosis | Possible oxygenase | 0.0037 | 0.0157 | 0.0289 |
Trypanosoma brucei | NADH-cytochrome b5 reductase-like protein | 0.0037 | 0.0157 | 0.0277 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0125 | 0.1833 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0162 | 0.2541 | 0.467 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Plasmodium falciparum | glutathione reductase | 0.0109 | 0.1526 | 0.2685 |
Leishmania major | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium vivax | ferredoxin--NADP reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Leishmania major | reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0326 | 0.5682 | 1 |
Echinococcus granulosus | NADH cytochrome b5 reductase 3 | 0.0037 | 0.0157 | 0.0157 |
Plasmodium falciparum | thioredoxin reductase | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Plasmodium vivax | glutathione reductase, putative | 0.0314 | 0.5442 | 0.9579 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Trypanosoma brucei | NADH-dependent fumarate reductase | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0109 | 0.1526 | 0.2685 |
Trypanosoma cruzi | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0314 | 0.5442 | 0.5442 |
Treponema pallidum | NADH oxidase | 0.0109 | 0.1526 | 0.8324 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0125 | 0.1833 | 1 |
Brugia malayi | flavodoxin family protein | 0.0125 | 0.1833 | 0.3226 |
Echinococcus multilocularis | lamin dm0 | 0.0032 | 0.0061 | 0.0061 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0125 | 0.1833 | 0.3226 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0125 | 0.1833 | 0.3226 |
Mycobacterium ulcerans | oxidoreductase | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium ulcerans | flavodoxin oxidoreductase | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium ulcerans | electron transfer protein FdxB | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | nitrate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma brucei | NADH-cytochrome b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0109 | 0.1526 | 1 |
Leishmania major | cytochrome-b5 reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0109 | 0.1526 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.005 | 0.0087 |
Loa Loa (eye worm) | hypothetical protein | 0.0326 | 0.5682 | 1 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0109 | 0.1526 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.0037 | 0.0157 | 0.0277 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0314 | 0.5442 | 1 |
Trypanosoma brucei | oxidoreductase-protein, putative | 0.0037 | 0.0157 | 0.0277 |
Loa Loa (eye worm) | glutathione reductase | 0.0314 | 0.5442 | 0.9579 |
Echinococcus multilocularis | NADH cytochrome b5 reductase 3 | 0.0037 | 0.0157 | 0.0157 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0326 | 0.5682 | 1 |
Leishmania major | trypanothione reductase | 0.0314 | 0.5442 | 0.9579 |
Onchocerca volvulus | 0.0032 | 0.0061 | 0.3868 | |
Treponema pallidum | ferredoxin-NADP(+) reductase subunit alpha | 0.0037 | 0.0157 | 0.0858 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0552 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0109 | 0.1526 | 1 |
Trypanosoma brucei | NADH-dependent fumarate reductase, putative | 0.0037 | 0.0157 | 0.0277 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0109 | 0.1526 | 0.2685 |
Echinococcus granulosus | cytochrome b5 reductase 4 | 0.0037 | 0.0157 | 0.0157 |
Echinococcus granulosus | methionine synthase reductase | 0.0201 | 0.3297 | 0.3297 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0109 | 0.1526 | 0.2685 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0109 | 0.1526 | 0.2685 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0037 | 0.0157 | 0.0277 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | < 20 % | Tested in vitro for the inhibition against C5a anaphylatoxin chemotactic receptor assayed on human monocyte cell line U937; Inactive at 30 microM | ChEMBL. | No reference |
Inhibition (binding) | < 20 % | Tested in vitro for the inhibition against C5a anaphylatoxin chemotactic receptor assayed on human monocyte cell line U937; Inactive at 30 microM | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.